C-Reactive Protein Testing Market by Assay Type (Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay), Disease Area (Cancer, Cardiovascular Diseases, Endometriosis), Detection Range, End-User - Global Forecast 2024-2030

C-Reactive Protein Testing Market by Assay Type (Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay), Disease Area (Cancer, Cardiovascular Diseases, Endometriosis), Detection Range, End-User - Global Forecast 2024-2030


The C-Reactive Protein Testing Market size was estimated at USD 1.50 billion in 2023 and expected to reach USD 1.69 billion in 2024, at a CAGR 12.41% to reach USD 3.42 billion by 2030.

Global C-Reactive Protein Testing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the C-Reactive Protein Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the C-Reactive Protein Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the C-Reactive Protein Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Alere Inc., BIOMÉRIEUX, BODITECH MED, Inc., CTK Biotech Inc., Danaher Corporation, DiaSorin S.p.A., Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Lumiradx Healthcare Private Limited, Merck KGaA, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, Inc., Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, and Zoetis Inc..

Market Segmentation & Coverage



This research report categorizes the C-Reactive Protein Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Assay Type
Chemiluminescence Immunoassay
Free T3
Free T4
Thyrotropin Levels
ELISA
Clinical
Nonclinical
Immunoturbidimetric Assay
Radioimmunoassay
Autoantibodies Against Thyrotropin Receptor
Human Serum Thyroglobulin Autoantibodies
Thyroperoxidase Autoantibodies
Disease Area
Cancer
Cardiovascular Diseases
Endometriosis
Inflammatory Bowel Disease
Lupus
Rheumatoid Arthritis
Detection Range
cCRP
Conventional CRP
hs-CRP
End-User
Assisted Living Healthcare Facilities
Clinics
Hospitals
Laboratories
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the C-Reactive Protein Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the C-Reactive Protein Testing Market?
3. What are the technology trends and regulatory frameworks in the C-Reactive Protein Testing Market?
4. What is the market share of the leading vendors in the C-Reactive Protein Testing Market?
5. Which modes and strategic moves are suitable for entering the C-Reactive Protein Testing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. C-Reactive Protein Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
5.1.2. Restraints
5.1.2.1. Issues associated with efficacy and specificity of C-Reactive protein testing
5.1.3. Opportunities
5.1.3.1. Technological advancements pertaining to conventional CRP tests
5.1.3.2. Research on C‐reactive protein in gastrointestinal diseases of dogs
5.1.4. Challenges
5.1.4.1. Stringent approval processes for testing techniques and products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. C-Reactive Protein Testing Market, by Assay Type
6.1. Introduction
6.2. Chemiluminescence Immunoassay
6.3.1. Free T3
6.3.2. Free T4
6.3.3. Thyrotropin Levels
6.3. ELISA
6.4.1. Clinical
6.4.2. Nonclinical
6.4. Immunoturbidimetric Assay
6.5. Radioimmunoassay
6.6.1. Autoantibodies Against Thyrotropin Receptor
6.6.2. Human Serum Thyroglobulin Autoantibodies
6.6.3. Thyroperoxidase Autoantibodies
7. C-Reactive Protein Testing Market, by Disease Area
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Diseases
7.4. Endometriosis
7.5. Inflammatory Bowel Disease
7.6. Lupus
7.7. Rheumatoid Arthritis
8. C-Reactive Protein Testing Market, by Detection Range
8.1. Introduction
8.2. cCRP
8.3. Conventional CRP
8.4. hs-CRP
9. C-Reactive Protein Testing Market, by End-User
9.1. Introduction
9.2. Assisted Living Healthcare Facilities
9.3. Clinics
9.4. Hospitals
9.5. Laboratories
10. Americas C-Reactive Protein Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific C-Reactive Protein Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa C-Reactive Protein Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam PLC
14.1.3. Alere Inc.
14.1.4. BIOMÉRIEUX
14.1.5. BODITECH MED, Inc.
14.1.6. CTK Biotech Inc.
14.1.7. Danaher Corporation
14.1.8. DiaSorin S.p.A.
14.1.9. Eurolyser Diagnostica GmbH
14.1.10. F. Hoffmann-La Roche Ltd.
14.1.11. Fujifilm Corporation
14.1.12. Getein Biotech, Inc.
14.1.13. HORIBA, Ltd.
14.1.14. Laboratory Corporation of America Holdings (LabCorp)
14.1.15. Lumiradx Healthcare Private Limited
14.1.16. Merck KGaA
14.1.17. Ortho Clinical Diagnostics
14.1.18. Quest Diagnostics Incorporated
14.1.19. Randox Laboratories Ltd.
14.1.20. SD Biosensor, Inc.
14.1.21. Sekisui Diagnostics
14.1.22. Siemens Healthineers AG
14.1.23. Thermo Fisher Scientific, Inc.
14.1.24. Trinity Biotech PLC
14.1.25. Zoetis Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
FIGURE 7. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
FIGURE 8. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
FIGURE 10. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2030 (%)
FIGURE 12. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings